ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.

2022 Insights on NRT Smoking Cessation Aids in the United States - ResearchAndMarkets.com

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
December 19, 2022 GMT

DUBLIN--(BUSINESS WIRE)--Dec 19, 2022--

The “NRT Smoking Cessation Aids in the US” report has been added to ResearchAndMarkets.com’s offering.

After years of reviewing Juul’s application to remain on the market, in June 2022 the US Food and Drug Administration (FDA) ordered the company to immediately stop selling its e-cigarette.

While critics of the company immediately celebrated the FDA ban, the reactions of Juul users were mixed. Some immediately flocked to retailers trying to secure remaining inventory, others stated that this was a sign to quit cold turkey, and a handful of users turned to NRT smoking cessations.

The NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

ADVERTISEMENT

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the NRT Smoking Cessation Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered:

NRT SMOKING CESSATION AIDS IN THE US

KEY DATA FINDINGS

2022 DEVELOPMENTS

  • FDA temporarily places ban on Juul products, leaving its status in the US market unclear
  • COVID-19 fears are left behind for many, and so is the desire to quit smoking
  • Embracing digital innovation and subscription services could open avenues for growth

PROSPECTS AND OPPORTUNITIES

Long-term impact of banning vaping devices unclear in the US

  • Regulation set to define the future of smoking and NRT cessation aids
  • Leading brands likely to explore opportunities in nicotine-free alternatives

CATEGORY INDICATORS

CATEGORY DATA

CONSUMER HEALTH IN THE US

EXECUTIVE SUMMARY

  • Consumer health in 2022: The big picture
  • 2022 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?

MARKET INDICATORS

MARKET DATA

ADVERTISEMENT

APPENDIX

  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
  • Summary 1 OTC: Switches 2021-2022

DISCLAIMER

DEFINITIONS

SOURCES

For more information about this report visit https://www.researchandmarkets.com/r/fwb0lx

Source: Euromonitor International

View source version on businesswire.com:https://www.businesswire.com/news/home/20221219005644/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: TOBACCO RETAIL

SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 12/19/2022 11:44 AM/DISC: 12/19/2022 11:44 AM

http://www.businesswire.com/news/home/20221219005644/en